There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cooper Co (COO – Research Report) and Mettler-Toledo (MTD – Research Report) with bullish sentiments.
Cooper Co (COO)
Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Cooper Co on January 16 and set a price target of $380.00. The company’s shares closed last Tuesday at $345.33.
According to TipRanks.com, Block is a 5-star analyst with an average return of
Currently, the analyst consensus on Cooper Co is a Moderate Buy with an average price target of $363.83, representing a 4.2% upside. In a report issued on January 11, Piper Sandler also maintained a Buy rating on the stock with a $375.00 price target.
See today’s best-performing stocks on TipRanks >>
Mettler-Toledo (MTD)
Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Mettler-Toledo on January 16 and set a price target of $1700.00. The company’s shares closed last Tuesday at $1531.30, close to its 52-week high of $1571.96.
According to TipRanks.com, Arias is a 2-star analyst with an average return of
Mettler-Toledo has an analyst consensus of Moderate Buy, with a price target consensus of $1469.83, a -5.0% downside from current levels. In a report issued on January 10, Wells Fargo also maintained a Buy rating on the stock with a $1650.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on COO:
- Cooper Companies price target raised to $375 from $350 at Piper Sandler
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Cooper Companies initiated with a Buy at Mizuho
- CooperCompanies Sets Annual Meeting and Stockholder Record Dates
- Piper Sandler medical tech analysts hold analyst/industry conference call
